Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.

1 Dec 1996

Abstract excerpt

OBJECTIVES: To determine the association between the epsilon2 and epsilon4 alleles of apolipoprotein E (ApoE) and independent measures of cognitive decline and non-cognitive symptomatology in late onset Alzheimer's disease. METHODS: The frequency of the epsilon2 and epsilon4 alleles of ApoE and their association with measures of cognitive decline and non-cognitive symptomatology were assessed in a population...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Biological Research and Disease Studies
Share to Dementia and Cognitive Impairment Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8971103
DOI: 10.1136/jnnp.61.6.580

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.PMID 8971103Read ↗

Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.Semantic proximity Read ↗

APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.Semantic proximity Read ↗

Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.Semantic proximity Read ↗

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.Semantic proximity Read ↗

Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E variants and cognition in healthy individuals: a critical opinion.Semantic proximity Read ↗

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.Semantic proximity Read ↗

[Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].Semantic proximity Read ↗

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.Semantic proximity Read ↗

Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.